Pasquale P. F.
- Country
- Italy
- Department
- Cardiologia
Research Overview
- Inclisiran for Prevention of Major Adverse Cardiovascular Events in High-Risk Primary Prevention Patients with Atherosclerotic Cardiovascular Disease
- A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk
- Phase 2 Randomized Double-Blind Placebo-Controlled Study of Tovinontrine in Adults with Heart Failure with Reduced Ejection Fraction
Data & Insights
Has run more than one trial at 512 of 1018 partner sites.
Specializations
Cardiovascular Disease Management
The investigator specializes in treating patients with atherosclerotic cardiovascular disease (ASCVD), focusing on both primary prevention and established disease management. Their research encompasses innovative therapeutic approaches for reducing major adverse cardiovascular events.
- Primary ASCVD Prevention
- Cardiovascular Risk Reduction
- Coronary Heart Disease Management
Key areas include interventions for coronary heart disease, myocardial infarction, and ischemic stroke prevention.
Heart Failure Treatment
The investigator conducts research in heart failure with reduced ejection fraction (HFrEF), evaluating novel therapeutic agents for improving cardiac function and patient outcomes.
- Chronic Heart Failure Management
- Cardiac Function Assessment
- Heart Failure Biomarkers
Their work includes evaluation of cardiac biomarkers such as NT-proBNP in heart failure patients.
Vascular Medicine
The investigator's expertise extends to comprehensive vascular disease management, including treatment of peripheral arterial conditions and urgent revascularization procedures.
- Peripheral Arterial Disease
- Acute Limb Ischemia
- Arterial Revascularization
Their research addresses various arterial conditions requiring medical intervention and revascularization.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.